We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Globe Scientific Acquired by L Squared Capital Partners

By LabMedica International staff writers
Posted on 02 May 2022
Print article
Image: L Squared Capital Partners has acquired Globe Scientific (Photo courtesy of Pexels)
Image: L Squared Capital Partners has acquired Globe Scientific (Photo courtesy of Pexels)

Globe Scientific (Mahwah, NJ, USA), a provider of laboratory consumable supplies, has been acquired by L Squared Capital Partners (Newport Beach, CA, USA), marking its third acquisition as part of GSI Group Holdings.

GSI Group is a collection of brands serving the biotech, clinical diagnostics, life sciences, education, and industrial sectors. With more than USD 100 million in revenue, GSI Group’s brands collectively offer a broad array of mission-critical lab-related consumable supplies, benchtop equipment, and related accessories to research, laboratory, clinical, academic, and industrial institutions across the world. GSI Group is aggressively pursuing acquisitions that provide chemicals and reagents, general and life science consumables, kits used in molecular biology applications, lab glassware, analytical instruments, and benchtop lab equipment to its target customer base. GSI Group is also seeking to expand its presence in high growth end markets such as biopharma, molecular diagnostics, and food safety testing. With its acquisition, Globe Scientific joins the existing GSI Group brands AmScope, Euromex, Omax, and Physix.

“My family and I are excited to partner with L Squared to become part of the GSI Group platform,” said Dara Diamond, President and CEO. “For the past 38 years, we have been passionate about providing a family-oriented culture for our employees while delivering five-star service and value to our customers and supply-chain partners. We are thrilled to join a platform of companies that share the same passion, vision, and corporate culture mindset.”

“Globe Scientific is an excellent addition to our consolidation thesis. We remain bullish on the long-term growth trajectory of scientific research and proud to be building a platform that supplies key products to the life sciences, clinical diagnostic, and academic research sectors,” said Randall Hunt, Partner at L Squared. “We are committed to supporting GSI Group’s growth both organically as well as via acquisitions of additional leading brands in the marketplace.”

Related Links:
Globe Scientific 
L Squared Capital Partners 

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: The fastGEN BCR::ABL1 Cancer kit offers a way to personalize treatment strategies for leukemia (Photo courtesy of BioVendor MDx)

First of Its Kind NGS Assay for Precise Detection of BCR::ABL1 Fusion Gene to Enable Personalized Leukemia Treatment

The BCR::ABL1 fusion gene plays a key role in the pathogenesis of several blood cancers, particularly chronic myeloid leukemia (CML). This gene results from a chromosomal translocation that causes constitutive... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The ePlex system has been rebranded as the cobas eplex system (Photo courtesy of Roche)

Enhanced Rapid Syndromic Molecular Diagnostic Solution Detects Broad Range of Infectious Diseases

GenMark Diagnostics (Carlsbad, CA, USA), a member of the Roche Group (Basel, Switzerland), has rebranded its ePlex® system as the cobas eplex system. This rebranding under the globally renowned cobas name... Read more

Pathology

view channel
Image: The new method is quick and easy, and can also be used by non-medical personnel. (Photo courtesy of Zoratto et al. Advanced Science 2024, edited)

New Blood Test Device Modeled on Leeches to Help Diagnose Malaria

Many individuals have a fear of needles, making the experience of having blood drawn from their arm particularly distressing. An alternative method involves taking blood from the fingertip or earlobe,... Read more